Table: Oncolys Biopharma -2023 parent results

Oncolys Biopharma

09/02/2024 06:00

Feb 9 (Reuters)- 
          Oncolys Biopharma Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended      Year ended       Year to       NEXT   
               Dec 31, 2023    Dec 31, 2022   Dec 31, 2024     YEAR     
                  LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS          RESULTS       FORECAST    H1 FORECAST 
  Sales           63 mln          976 mln                               
               (-93.5 pct)      (+51.9 pct)                             
  Operating     loss 1.93        loss 1.20                              
  Recurring     loss 1.91        loss 1.16                              
  Net           loss 1.94        loss 1.15                              
  EPS        loss 108.92 yen  loss 66.31 yen                            
  Ann Div          NIL              NIL            NIL                  
  -Q2 Div          NIL              NIL            NIL                  
  -Q4 Div          NIL              NIL            NIL                  
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T